245 related articles for article (PubMed ID: 32560227)
1. Vaccines and Therapies in Development for SARS-CoV-2 Infections.
Wu D; Koganti R; Lambe UP; Yadavalli T; Nandi SS; Shukla D
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560227
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
Hon KL; Leung KKY; Leung AK; Qian SY; Chan VP; Ip P; Wong IC
Drugs Context; 2020; 9():. PubMed ID: 32655654
[TBL] [Abstract][Full Text] [Related]
3. Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.
Nabil A; Uto K; Elshemy MM; Soliman R; Hassan AA; Ebara M; Shiha G
EXCLI J; 2020; 19():992-1016. PubMed ID: 32788913
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
[TBL] [Abstract][Full Text] [Related]
5. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
Glinsky GV
Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
[TBL] [Abstract][Full Text] [Related]
6. The journey of remdesivir: from Ebola to COVID-19.
Pardo J; Shukla AM; Chamarthi G; Gupte A
Drugs Context; 2020; 9():. PubMed ID: 32547625
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
Park SE
Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
[TBL] [Abstract][Full Text] [Related]
8. Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19.
Lee P; Kim DJ
Immune Netw; 2020 Aug; 20(4):e28. PubMed ID: 32895615
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.
TaŞtan C; Yurtsever B; Sir KarakuŞ G; Dİlek KanÇaĞi D; Demİr S; Abanuz S; Seyİs U; Yildirim M; Kuzay R; Elİbol Ö; Arbak S; AÇikel Elmas M; BİrdoĞan S; Sezerman OU; KocagÖz AS; YalÇin K; Ovali E
Turk J Biol; 2020; 44(3):192-202. PubMed ID: 32595356
[TBL] [Abstract][Full Text] [Related]
10. Emerging Prevention and Treatment Strategies to Control COVID-19.
Singh VK; Mishra A; Singh S; Kumar P; Singh M; Jagannath C; Khan A
Pathogens; 2020 Jun; 9(6):. PubMed ID: 32585805
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Antiviral and Treatment Candidates: Current Status.
Españo E; Kim D; Kim J; Park SK; Kim JK
Immune Netw; 2021 Feb; 21(1):e7. PubMed ID: 33728100
[TBL] [Abstract][Full Text] [Related]
12. Is Pakistan's Response to Coronavirus (SARS-CoV-2) Adequate to Prevent an Outbreak?
Javed B; Sarwer A; Soto EB; Mashwani ZU
Front Med (Lausanne); 2020; 7():158. PubMed ID: 32373620
[No Abstract] [Full Text] [Related]
13. Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19.
Barbosa JR; de Carvalho Junior RN
Trends Food Sci Technol; 2021 Feb; 108():223-235. PubMed ID: 33424125
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies.
Khan K; Dimtri F; Vargas C; Surani S
Cureus; 2020 May; 12(5):e8206. PubMed ID: 32577324
[TBL] [Abstract][Full Text] [Related]
15. Metallo-antiviral aspirants:
Mehrotra R; Shukla SN; Gaur P
Eur J Med Chem Rep; 2023 Aug; 8():100104. PubMed ID: 37035854
[TBL] [Abstract][Full Text] [Related]
16. Timelines of COVID-19 vaccines.
Chugh T
Curr Med Res Pract; 2020; 10(4):137-138. PubMed ID: 32839724
[No Abstract] [Full Text] [Related]
17. RNA to the rescue: RNA is one of the most promising targets for drug development given its wide variety of uses.
Rinaldi A
EMBO Rep; 2020 Jul; 21(7):e51013. PubMed ID: 32588530
[TBL] [Abstract][Full Text] [Related]
18. Researchers highlight 'questionable' data in Russian coronavirus vaccine trial results.
Abbott A
Nature; 2020 Sep; 585(7826):493. PubMed ID: 32934375
[No Abstract] [Full Text] [Related]
19. COVID vaccines: the world's medical regulators need access to open data.
Nature; 2020 Dec; 588(7837):195. PubMed ID: 33293720
[No Abstract] [Full Text] [Related]
20. Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
Gupta RK
Nat Rev Immunol; 2021 Jun; 21(6):405. PubMed ID: 33972765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
